Associations between pulmonary function disorders & Metabolic Syndrome: A Cross-Sectional Study Using Data from KNHANES 2008-2013

폐기능 장애와 대사 증후군 관련성: 2008-2013 국민건강 영양조사 자료 사용 단면연구

  • Kang, Sun-Hee (Department of Medical Information Management, Kongju National University) ;
  • Boo, Yoo-Kyung (Department of Healthcare Management, Eulji University) ;
  • Ahn, Byung-Ki (Department of Health Care Management, WooSong University)
  • 강선희 (공주대학교 의료정보학과) ;
  • 부유경 (을지대학교 의료경영학과) ;
  • 안병기 (우송대학교 보건의료경영학과)
  • Received : 2017.08.16
  • Accepted : 2017.11.03
  • Published : 2017.11.30


This study was conducted to identify relationships between lung function disorders and Metabolic Syndrome(MetS) that have common comorbidities such as Cardio Vascular Diseases(CVD). According to the hypothesis that there may be a significant relationship between them, analyses were conducted to identify the proper management point for those diseases. Overall, 53,829 data were taken from KNHANES 2008-2013. Included data were PFT(Pulmonary Function Test) done and age over 40. All the 14 confounders applied, only 8,137 cases (M:3,951, F:4,186) were left. Low pulmonary function was divided into two categories, obstructive and restrictive patterns, based on the Global Initiative for Chronic Obstructive Lung Disease(GOLD) criteria, while MetS was defined based on the revised NCEP-ATPIII criteria. The relationships between those diseases were analyzed using logistic regression analysis. In addition, for the prevalence rate, cross-tab analysis were conducted. There were no significant relationships observed between obstructive lung disease and MetS, but a restrictive pattern had a meaningful relationship with MetS. Specifically, MetS showed a higher prevalence rate for both obstructive and restrictive pattern patients than the control group. Restrictive pattern patients showed a higher prevalence rate to MetS than obstructive patients. Overall, restrictive lung patterns showed a meaningful association with MetS, but not with obstructive patterns. Additionally, the prevalence rate of MetS among restrictive patients was higher than among obstructive patients.

본 연구는 심혈관 질환을 공통적으로 동반하는 폐기능 장애와 대사증후군 관계에 대한 연구이다. 이들 질환이 상호 관련성이 있다는 가정 하에 폐기능 장애와 대사증후군간의 상호 관련성 여부를 확인하여 올바른 질환 관리를 위한 초석을 마련하고자 하였다. 자료는 국민건강 영양조사 자료중 2008년부터 2013년까지 6년간 자료를 통합한 53,829건에서, 폐기능 검사를 시행한 만 40세 이상으로 모든 혼란 변수를 통제한 정제된 자료 8,137명(남자, 3,951명, 여자 4,186명)의 자료를 사용하였다. 폐기능 장애는 GOLD(Global Initiative for Chronic Obstructive Lung Disease)기준에 따라 폐쇄성, 제한성으로 구분하였고, 대사증후군은 개정된 NCEP-ATPIII(National Cholesterol Education Program-Expert Panel-Adult Treatment Panel III)기준을 사용하였다. 연관성 분석은 로지스틱 회귀분석을, 유병률은 교차 분석을 시행하였다. 연구 결과, 연관성 분석에서 폐쇄성 폐질환은 대사증후군과 직접적인 관련성을 보이지 않았으며 제한성 폐질환은 대사증후군과 직접적인 관련성을 보였다. 유병률 분석에서는 폐쇄성 폐질환과 제한성 폐질환 모두 대조군보다 높은 대사증후군 유병률을 보였다. 그러나 제한성 폐질환의 대사증후군 유병률이 폐쇄성 폐질환의 대사증후군 유병률보다 더 높았다. 결론적으로 폐쇄성이 아니라 제한성 폐질환이 대사증후군과 유의한 연관성을 보였고 대사증후군 유병률도 더 높았다.



  1. COPD Guideline Revision Committee, COPD Guideline Revised 2014; The Korean Academy of Tuberculosis and Respiratory Diseases, Seoul, Korea, c2014[cited 2016 Aug. 23]Available from, (accessed Nov. 20, 2016)
  2. Global Initiative for Chronic Obstructive Lung Disease.(GOLD): Teaching Slide Set, GOLD, [cited Jan. 2015] Available from: (accessed Nov. 27, 2016)
  3. G. M. Reaven, "Role of insulin resistance in human disease", Diabetes, vol. 37, pp. 1595-1607, Dec. 1988.
  4. A. Tiengo, G. P. Fadini, A. Avogaro "The metabolic syndrome, diabetes and lung dysfunction", Diabetes & Metabolism, vol. 34. no. 5 pp. 447-454, Nov. 2008. DOI:
  5. G. Fantuzzi, "Adipose tissue, adipokines, and inflammation", J Allergy Clin Immunol, vol. 115, no. 5, pp. 911-919, May. 2005. DOI:
  6. E. Kern, "Metabolic Syndrome and Systemic Inflammation in COPD", COPD: Journal of Chronic Obstructive Pulmonary Disease, vol. 8, no. 6, pp. 395-396, Dec. 2011. DOI:
  7. J. H. Chung, H. J. Hwang, C. H. Han, B. S. Son, D. H. Kim, M. S. Park, "Association between Sarcopenia and Metabolic Syndrome in Chronic Obstructive Pulmonary Disease: The Korea National Health and Nutrition Examination Survey (KNHANES) from 2008 to 2011", COPD: JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE Informa Healthcare USA, Inc. COPD, vol. 12, no. 1, pp. 82-89, Jun. 2014. DOI:
  8. E. S. FORD, T. J. Cunningham, C .I. Mercado, "Lung function and metabolic syndrome: Findings of National Health and Nutrition Examination Survey 2007-2010", Journal of Diabetes vol. 6, no. 6, pp. 603-613, Mar. 2014. DOI:
  9. Y. J. Paek, K. S. Jung, Y. I. Hwang, K. S. Lee, D. R. Lee, J. U. Lee, "Association between low pulmonary function and metabolic risk factors in Korean adults: the Korean National Health and Nutrition Survey", Metabolism Clinical and Experimental, vol. 59, no. 9, pp. 1300-1306, Sep. 2010. DOI:
  10. W. Y. Lin, C. A. Yao, H. C. Wang, K. C. Huang, "Impaired lung function is associated with obesity and metabolic syndrome in adults", Obesity vol. 14. no. 9, pp. 1654-1661, Sep. 2006. DOI:
  11. K. Nakajima, Y. Kubouchi, T. Muneyuki, M. Ebata, S. Eguchi, H. Munakata, Committee for the Diagnostic Criteria of Metabolic Syndrome, "A Possible Association Between Suspected Restrictive Pattern as Assessed by Ordinary Pulmonary Function Test and the Metabolic Syndrome", Chest, vol. 134, no. 4, pp. 712-718. Oct. 2008 DOI:
  12. L. Dave, S. Garde, O. A. Ansari, N. Shrivastava, V. K. Sharma, "A Study of association between metabolic syndrome and COPD", Journal of Evolution of Medical and Dental Sciences, vol. 3, no. 22, pp. 6183-6188, Jun. 2014. DOI:
  13. K.B.H. Lam, R. E. Jordan, C. Q. Jiang, G. N. Thomas, M. R. Miller, W. S. Zhang, T. H. Lam, K. K. Cheng, P. Adab, "Airflow obstruction and metabolic syndrome: the Guangzhou Biobank Cohort Study", European Respiratory Journal vol. 35, no. 2, pp. 317-323, July. 2009. DOI:
  14. F. C. Hsiao, C. Z. Wu, S. C. Su, M. T. Sun, C. H. Hsieh, Y...J Hung, C.. T.He, D. Pei, "Baseline forced expiratory volume in the first second as an independent predictor of development of the metabolic syndrome", Metabolism Clinical and Experimental vol. 59, no. 6, pp. 848-853, Jun. 2010. DOI:
  15. J. S. Rana,, M. A. Mittleman, J. Sheikh, F. B. Hu, J. E. Manson, G. A. Colditz, F. E. Speizer, R. G. Barr, C. A. Camargo, "Chronic obstructive pulmonary disease, asthma and risk of type 2 diabetes in women." Diabetes Care, vol. 27, no. 10, pp. 2478-84, Oct. 2004. DOI:
  16. S. M. Grundy, J I. Cleeman, S. R. Daniels, K. A. Donato, R. H. Eckel, B. A. Franklin, D. J. Gordon, R. M. Krauss, P. J. Savage, S. C. Smith, J. A. Spertus and F. Costa, "Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement", Circulation, vol. 112, no. 17, pp. 2735-2752, Oct. 2005. DOI:
  17. H. K. Kim, K. H. Choi, S. W. Lim, H. S. Rhee, "Development of Prediction Model for Prevalence of Metabolic Syndrome Using Data Mining: Korea National Health and Nutrition Examination Study" Journal of Digital Convergence, vol. 14, no. 2, pp. 325-33, Feb. 2016. DOI :
  18. K. R. Park, Y. C. Cho, "Prevalence Rates of Risk Factors of Metabolic Syndrome, and Its Related with Obesity Indices Among the Health Checkup Examines," Journal of the Korea Academia- Industrial cooperation Society, vol. 17, no. 3, pp. 153-162, Mar. 2016. DOI :
  19. H. J. Yoon, S. K. Lee, "The Incidence and Risk Factors of Metabolic Syndrome in Rural Area", Journal of the Korea Academia-Industrial cooperation Society, vol. 16, no. 6, pp. 3934-3943, Jun. 2015. DOI:
  20. Y. C. Cho, I. S. Kwon, J. Y. Park, M. W Shin, "Prevalence of Metabolic Syndrome and Its Associated Factors among Health Checkup Examinees in a University Hospital", Journal of the Korea Academia-Industrial cooperation Society, vol. 13, no. 11, pp. 5317-5325, Nov. 2012. DOI:
  21. S. H Landis, H. Muellerova,.D.M Mannino, A.M Menezes, M. K Han, Thys van der Molen, M. Ichinose, Z. Aisanov, Y. M. Oh, K. J Davis, "Continuing to Confront COPD International Patient Survey: methods, COPD prevalence, and disease burden in 2012-2013", International Journal of COPD, no. 9, pp. 597-611, Jun. 2014. DOI:
  22. P. Ranasinghe, Y. Mathangasinghe, R. Jayawardena, A. P. Hills and A. Misra, "Prevalence and trends of metabolic syndrome among adults in the asia-pacific region: a systematic review", BMC Public Health, vol. 17, no. 101, Jan. 2017. DOI:
  23. N. C. Lipovec, R.J. Beijers, B.V.D Borst, W. Doehner, M. Lainscak & Annemie M. W. J. Schols, "The Prevalence of Metabolic Syndrome In Chronic Obstructive Pulmonary Disease: A Systematic Review", journal COPD, Journal of Chronic Obstructive Pulmonary Disease, vol. 13, no. 3, PP 399-406, Feb. 2016. DOI:
  24. S. H. Beigh, S. Jain, "Prevalence of metabolic syndrome and gender differences", Bio Information, vol. 8, no. 13, pp. 613-616, Jul. 2012
  25. H. Watz, B. Waschki, A. Kirsten, K. C. Müller, G. Kretschmar, T. Meyer, O.Holz, H. Magnussen, "The Metabolic Syndrome in Patients With Chronic Bronchitis and COPD: Frequency and Associated Consequences for Systemic Inflammation and Physical Inactivity", Chest, vol. 136, no. 4, Oct. 2009. DOI:
  26. Y. S. Jo, S. M. Choi, J. W. Lee, Y. S. Park, S. M. Lee, J. J. Yim, C. G. Yoo, Y. W. Kim, S. K Han, C. H. Lee "The Relationship Between Chronic Obstructive Pulmonary Disease and Comorbidities: A Cross-Sectional Study Using Data from KNHANES 2010-2012", Respiratory Medicine, vol. 109, no. 1, Jan, 2015. DOI:
  27. H. C. Yeh, N. M. Punjabi, N. Y. Wang, J. S, Pankow, B. B. Duncan, C. E. Cox E. Selvin, F. L. Brancati, "Cross-Sectional and Prospective Study of Lung Function in Adults with Type 2 Diabetes: the Atherosclerosis Risk in Communities (ARIC) Study", Diabetes Care, vol. 31, pp. 741-6, Apr. 2008. DOI:
  28. D. A. Lawlor, S. Ebrahim, G. D. Smith. "Associations of measures of lung function with insulin resistance and Type 2 diabetes: findings from the British Women's Heart and Health Study, Diabetologia 47, no. 2, pp. 195-203, Feb. 2004. DOI:
  29. F. M. E. Franssen, D. E. O'Donnell, G. H. Goossens, E. E. Blaak, A. W. J. Schols, "Obesity and the lung: 5. Obesity and COPD", Thorax 63, no. 12, pp. 1110-1117, Apr. 2008. DOI:
  30. S. K. Kim, J. C. Bae, J. H. Baek, J. H. Jee, K. Y. Hur, M. K. Lee, J. H. Kim, "Decline in lung function rather than baseline lung function is associated with the development of metabolic syndrome: A six-year longitudinal study",, Mar. 2017. DOI:
  31. D. M. Mannino, D. Thorn, A. Swensen, F. Holguin. "Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD", Eur Respir J, vol. 32, no. 4. pp. 962-969, Jun. 2008. DOI:
  32. L. M. G. Steuten, E. C. Creutzberg, H. J .M. Vrijhoef, E. F. Wouters, "COPD as a multicomponent disease: Inventory of dyspnoea, underweight, obesity and fat free mass depletion in primary care", Primary Care Respiratory Journal, vol. 15, no. 2, pp. 84-91, Apr. 2006. DOI: